{
    "nctId": "NCT01554943",
    "briefTitle": "Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients",
    "officialTitle": "Late Cardiac Evaluation of the Three Arm Belgian Trial A Phase III Randomized Trial Involving Node-positive Early Breast Cancer Patients With a Long Median Follow-up (~ 15 Years)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 73,
    "primaryOutcomeMeasure": "Late cardiac toxicity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Alive, free of any recurrence, Not lost to follow-up\n* Last workup should be no older than 1 year to exclude relapses. If this is older than 1 year, a new workup (PE, blood tests and MMG) will be performed prior to the entry in this study\n* Patients previously diagnosed with CHF who are free of recurrence will also be invited to participate, if there is no contra-indication\n* Patients should be able to perform the prescribed assessments\n\nExclusion Criteria:\n\n* Death\n* Breast cancer recurrence\n* Unwilling to perform exams as per protocol",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}